Outlook Therapeutics Inc

NASDAQ:OTLK   4:00:00 PM EDT
7.90
+0.37 (+4.91%)
: $8.18 +0.28 (+3.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Outlook Therapeutics Inc Stock, NASDAQ:OTLK

111 South Wood Avenue, Unit 100, Iselin, New Jersey 08830
United States of America
Phone: +1.609.619.3990
Number of Employees: 24

Description

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.